The Effect of Ginkgo biloba on sexual dysfunction in patients with breast cancer;A randomized double blind placebo – controlled clinical trial
- Conditions
- breast cancer.Family history of malignant neoplasm of breast
- Registration Number
- IRCT2016012414477N3
- Lead Sponsor
- Mashhad University of Medical Sciences, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 52
Being married;18 years of age or older; At least 2 month after the end of treatment; Signed and dated written informed consent prior to admission to the study;The ability to speak; understand the Persian; Patients who had undergone breast cancer surgery
Exclusion criteria:
not having sex at least twice during the study period; Having any other medical; conditions such as:
cardiovascular diseases ( i.e. uncontrolled hypertension, history of infarction, deep-vein thrombosis), Pulmonary diseases (i.e. asthma, shortness of breath), Neurological diseases ( i.e. convulsions, epilepsy, migraine, cerebrovascular disorder), History of bleeding disorder, kidney diseases, liver diseases, endocrine disorders (i.e. diabetes), mental disorders, coagulation disorders; Other malignancies other than breast cancer;Infertility; Stressful event (other than cancer) during the last 6 months (e.g. traumatic and stressful event, changes in living conditions such as relocation, financial ruin, marital problems, losing a close family member); Failing to follow the treatment plan; A history of psychiatric disorder; Patients taking SSRI 2 weeks prior to study; Anticoagulant therapy (Heparin, enoxaparin, warfarin, clopidogrel, ticlopidine) 2 weeks prior to study; Patients with hormone-receptor (HR)-positive breast cancer.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Female Sexual Function Index score. Timepoint: Before and after intervention. Method of measurement: Female Sexual Function Index scale.
- Secondary Outcome Measures
Name Time Method